Related Experiment Video

Updated: May 12, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Clinical and molecular features of POLG-related mitochondrial disease

Jeffrey D Stumpf1, Russell P Saneto, William C Copeland

  • 1Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.

Cold Spring Harbor Perspectives in Biology
|April 3, 2013
PubMed

Insights

Mitochondrial DNA polymerase (pol γ) defects cause POLG-related diseases. This chapter details clinical symptoms, molecular causes, and novel therapeutic strategies for these debilitating conditions.

Area of Science:

  • Mitochondrial Biology
  • Genetics
  • Neurology

Background:

  • Defects in mitochondrial DNA replication, specifically by the mitochondrial DNA polymerase (pol γ), are linked to various inherited diseases.
  • Mutations in the POLG gene, encoding pol γ, are associated with a spectrum of severe conditions including Alpers-Huttenlocher syndrome and progressive external ophthalmoplegia (PEO).

Purpose of the Study:

  • To provide a comprehensive overview of POLG-related mitochondrial diseases.
  • To elucidate the clinical presentations, molecular mechanisms, and therapeutic avenues for these disorders.

Main Methods:

  • Review of clinical data and genetic analyses of POLG mutations.
  • Molecular characterization of polymerase activity and holoenzyme formation.
  • Exploration of exonuclease activity, mutagenesis, and novel therapeutic research.

Main Results:

  • Identified distinct clinical symptoms differentiating various POLG-related diseases.
  • Characterized molecular defects in pol γ activity and the impact of holoenzyme formation.
  • Highlighted the role of pol γ exonuclease activity in disease pathogenesis and aging.

Conclusions:

  • Understanding POLG mutations and their functional consequences is crucial for diagnosing and managing mitochondrial diseases.
  • Novel therapeutic strategies targeting pol γ replication are under development to address toxicity and improve patient outcomes.

More Related Videos

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...